瑞士诺华的地拉罗司可用来治疗什么病症

Also known as Enrig, it is an iron chelator product developed by Novartis in Switzerland. It was approved for marketing in the United States in 2005. It is also the first oral iron anthelmintic approved by the US FDA for routine use. It is currently mainly used for patients with iron accumulation caused by long-term blood transfusions (such as those with thalassemia or other rare anemias). It is suitable for children over two years old and adults.

Switzerland's Novartis is one of the world's three largest pharmaceutical companies and is committed to continuously researching, developing and promoting innovative products to help humans cure diseases, relieve pain and improve quality of life. Its business units include innovative drugs (Novartis), eye care (Alcon), generic drugs (Sanderz), vaccines, and animal health products, and are world leaders in these fields.

Thalassemia, also known as thalassemia, is common in the Mediterranean, Southeast Asia and other regions. It is a group of fatal and disabling genetic blood diseases that seriously threaten human health. Novartis' deferasirox is highly selective for iron (Fe3+). It is a ligand with 3 protrusions that binds iron with high affinity in a 2:1 ratio. In 2010, deferasirox dispersible tablets were approved for marketing in China, bringing new treatment options to domestic patients. Patients have good compliance and ensure long-term iron removal treatment.

Deferasirox is administered orally. The recommended starting daily dose is 20 mg/kg, once a day. It needs to be taken on an empty stomach at least 30 minutes before a meal. It is best to take it at the same time every day. Deferasirox should not be taken together with aluminum-containing antacids and should not be used by those who are allergic to deferasirox or any of its ingredients.

The above is the introduction of the indications of Swiss Novartis. As a prescription drug, patients are asked to start treatment with deferasirox under the guidance of a professional doctor.

Recommended related hot articles: /newsDetail/93986.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.